Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Quality of life for prostate cancer patients varies by type of treatment, study reveals

Quality of life after prostate cancer treatment varies by the type of treatment patients receive, a new study reveals.

20 Apr 2017

Doctors perform first-ever robotic, minimally-invasive surgical removal of stage IV tumor thrombus

A surgical team at Keck Medicine of the University of Southern California has pushed the boundaries of clinical care by performing the first-ever robotic, minimally-invasive surgical removal of a stage IV tumor thrombus, which is when a kidney cancer tumor extends into the heart.

19 Apr 2017

Addressing unmet needs in prostate cancer

Prostate cancer is the second most diagnosed cancer globally with over a million men diagnosed worldwide. We are fortunate in that better diagnostic techniques and better awareness means that men are often being diagnosed earlier, which gives them a better chance of being cured.

19 Apr 2017

Bacteriophages may help combat antibiotic-resistant 'superbugs'

Viruses that specifically kill bacteria, called bacteriophages, might one day help solve the growing problem of bacterial infections that are resistant to antibiotic treatment.

18 Apr 2017

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

In the past, all forms of metastatic prostate cancer have been considered incurable. In recent years, the FDA has approved six drugs for men with metastatic disease, all of which can increase survival.

18 Apr 2017

Differences found in cancer occurrence within African and US born blacks

The cancer profile of African-born blacks differs from that of United States-born blacks and varies by region of birth, according to a new study. The study, appearing in CANCER, suggests differences in environmental, cultural, social, and genetic factors, and points to an opportunity to study the risk factors associated with the cancer burden in African-born blacks to help create targeted interventions.

14 Apr 2017

U.S. Preventive Services Task Force supports Prostate Cancer Screening in men aged 55–69

The Men's Health Network (MHN) is positive on the most recent recommendations of the U.S. Preventive Services Task Force (USPSTF). The task force states that the choice of whether to be screened or not for prostate cancer depends on the men.

12 Apr 2017

High level of protein appears to diminish energy burning power of brown fat

Too much of a protein already associated with prostate cancer appears to also diminish the energy burning power of brown fat, scientists report.

10 Apr 2017

MIT engineers develop more sensitive approach to reveal ovarian tumors

Most ovarian cancer is diagnosed at such late stages that patients' survival rates are poor. However, if the cancer is detected earlier, five-year survival rates can be greater than 90 percent.

10 Apr 2017

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Men who attended a structured yoga class twice a week during prostate cancer radiation treatment reported less fatigue and better sexual and urinary function than those who didn't, according to a clinical trial led by the Perelman School of Medicine at the University of Pennsylvania.

6 Apr 2017

Family history does not appear to increase risk of prostate cancer progression, analysis reveals

Active surveillance-careful monitoring to determine if or when a cancer warrants treatment-is an increasingly prevalent choice for prostate cancer, but it's unclear if the strategy is appropriate for men with a family history of prostate cancer.

6 Apr 2017

Protein testing may become potential tool to detect prostate cancer

In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways clinicians can detect prostate cancers in their patients.

5 Apr 2017

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

As the population of people living with HIV in the United States ages, the burden of cancer for these patients is expected to shift away from cancers linked to AIDS and toward malignancies that affect the general population, according to a new study led by a University of North Carolina at Chapel Hill researcher.

5 Apr 2017

Scientists find new way to detect prostate cancer by 'sniffing' urine

On the list of dreaded medical tests, a prostate biopsy probably ranks fairly high. The common procedure requires sticking a needle into the prostate gland to remove tissue for assessment.

4 Apr 2017

Extreme short and long telomeres linked to increased cancer risk

The length of the telomere "caps" of DNA that protect the tips of chromosomes may predict cancer risk and be a potential target for future therapeutics, University of Pittsburgh Cancer Institute scientists will report today at the AACR Annual Meeting in Washington, D.C.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

Northwestern Memorial Hospital is now home to the Chicago area's first combined magnetic resonance and positron emission tomography scanner, a machine that shortens the total time a patient spends in imaging tests while providing exceptional image quality at lower doses of radiation.

31 Mar 2017

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

QIAGEN N.V. today announced it is commercializing the Research use only AdnaTest Prostate Cancer Panel AR-V7 to detect the androgen receptor splice variant 7 (AR-V7) from liquid biopsies to investigate resistance to potential drugs for advanced prostate cancer.

From QIAGEN Manchester Limited 31 Mar 2017

New research to explore how socio-economic factors, other health concerns affect cancer treatment

How do health and socio-economic factors impact the nearly 1.7 million people diagnosed with cancer each year? RTI International plans to explore this through a new Robert Wood Johnson Foundation grant.

31 Mar 2017

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Quality of life for prostate cancer patients varies by type of treatment, study reveals

Doctors perform first-ever robotic, minimally-invasive surgical removal of stage IV tumor thrombus

Addressing unmet needs in prostate cancer

Bacteriophages may help combat antibiotic-resistant 'superbugs'

Combined treatment regimen shows early promise in eliminating metastatic prostate cancer

Differences found in cancer occurrence within African and US born blacks

U.S. Preventive Services Task Force supports Prostate Cancer Screening in men aged 55–69

High level of protein appears to diminish energy burning power of brown fat

MIT engineers develop more sensitive approach to reveal ovarian tumors

Clinical study examines impact of yoga on side-effects caused by prostate cancer treatment

Family history does not appear to increase risk of prostate cancer progression, analysis reveals

Protein testing may become potential tool to detect prostate cancer

Number of HIV-positive cancer patients in the U.S. projected to decrease through 2030

Scientists find new way to detect prostate cancer by 'sniffing' urine

Extreme short and long telomeres linked to increased cancer risk

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Northwestern Memorial first in Illinois to integrate combined MR-PET scanner into health care system

QIAGEN announces commercialization of AdnaTest kit for clinical research in prostate cancer

New research to explore how socio-economic factors, other health concerns affect cancer treatment

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in